Red-Light Photodynamic Therapy with 10% Aminolevulinic Acid (ALA) Following Microneedling in the Treatment of Facial Actinic Keratosis: Cosmetic and Clinical Outcomes
We evaluated the cosmetic outcome and clearance of actinic keratoses (AKs) using photodynamic therapy (PDT) with microneedling-assisted delivery of 10% aminolevulinic acid (ALA) gel (Ameluz®, Biofrontera, Woburn, MA) with 30-minute incubation followed by 10-minute illumination with a red light (BF-R...
Saved in:
Published in | The Journal of clinical and aesthetic dermatology Vol. 18; no. 4; pp. 51 - 56 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Matrix Medical Communications
01.04.2025
|
Subjects | |
Online Access | Get full text |
ISSN | 1941-2789 2689-9175 |
Cover
Loading…
Abstract | We evaluated the cosmetic outcome and clearance of actinic keratoses (AKs) using photodynamic therapy (PDT) with microneedling-assisted delivery of 10% aminolevulinic acid (ALA) gel (Ameluz®, Biofrontera, Woburn, MA) with 30-minute incubation followed by 10-minute illumination with a red light (BF-RhodoLED®, 635nm, 37 J/cm
).
Five subjects were treated with red light PDT using microneedling-assisted delivery of 10% ALA gel. ALA gel was applied on the face and incubated for 30 minutes without occlusion, followed by illumination with a red light for 10 minutes (635nm, 37 J/cm
). Follow-up (FU) visits were made at Weeks 1, 2, 4, and 8. The primary endpoints were changes in subject- and investigator-graded Global Aesthetic Improvement Scale (GAIS) scores and assessment of quality in wrinkle, color evenness, texture, spot, and pore analyses with Canfield Visia-CR imaging system. Secondary endpoints were: 1) AK clearance as quantified by the count of AKs at eight-week FU versus baseline and 2) safety as measured by subject-reported pain (10-point VAS scale) during red-light illumination and adverse events.
Investigator- and subject-graded GAIS scores showed a sharp increase to "much improved" at two weeks and increased to "very much improved" at eight weeks. There was an average 24.93-percent improvement in texture and an average 10.30-percent improvement in skin tone (color) evenness. AK lesion clearance ranged from 70 to 100 percent, with the mean at 89.2±14.9 percent. Three subjects achieved 100-percent clearance. The mean pain score during red-light illumination was 3.2±1.6. All subjects completed the study.
The study included a small number of subjects (N=5).
Our results indicate that red light PDT using microneedling-assisted delivery of 10% ALA gel and a short 30-minute incubation is a safe and tolerable procedure producing good cosmetic outcomes in several skin quality parameters, such as texture and skin tone evenness, as well as an AK lesion clearance rate of 89.2 percent at Week 8, relatively low pain scores, and a reduced PDT treatment time. |
---|---|
AbstractList | We evaluated the cosmetic outcome and clearance of actinic keratoses (AKs) using photodynamic therapy (PDT) with microneedling-assisted delivery of 10% aminolevulinic acid (ALA) gel (Ameluz®, Biofrontera, Woburn, MA) with 30-minute incubation followed by 10-minute illumination with a red light (BF-RhodoLED®, 635nm, 37 J/cm2).ObjectiveWe evaluated the cosmetic outcome and clearance of actinic keratoses (AKs) using photodynamic therapy (PDT) with microneedling-assisted delivery of 10% aminolevulinic acid (ALA) gel (Ameluz®, Biofrontera, Woburn, MA) with 30-minute incubation followed by 10-minute illumination with a red light (BF-RhodoLED®, 635nm, 37 J/cm2).Five subjects were treated with red light PDT using microneedling-assisted delivery of 10% ALA gel. ALA gel was applied on the face and incubated for 30 minutes without occlusion, followed by illumination with a red light for 10 minutes (635nm, 37 J/cm2). Follow-up (FU) visits were made at Weeks 1, 2, 4, and 8. The primary endpoints were changes in subject- and investigator-graded Global Aesthetic Improvement Scale (GAIS) scores and assessment of quality in wrinkle, color evenness, texture, spot, and pore analyses with Canfield Visia-CR imaging system. Secondary endpoints were: 1) AK clearance as quantified by the count of AKs at eight-week FU versus baseline and 2) safety as measured by subject-reported pain (10-point VAS scale) during red-light illumination and adverse events.MethodsFive subjects were treated with red light PDT using microneedling-assisted delivery of 10% ALA gel. ALA gel was applied on the face and incubated for 30 minutes without occlusion, followed by illumination with a red light for 10 minutes (635nm, 37 J/cm2). Follow-up (FU) visits were made at Weeks 1, 2, 4, and 8. The primary endpoints were changes in subject- and investigator-graded Global Aesthetic Improvement Scale (GAIS) scores and assessment of quality in wrinkle, color evenness, texture, spot, and pore analyses with Canfield Visia-CR imaging system. Secondary endpoints were: 1) AK clearance as quantified by the count of AKs at eight-week FU versus baseline and 2) safety as measured by subject-reported pain (10-point VAS scale) during red-light illumination and adverse events.Investigator- and subject-graded GAIS scores showed a sharp increase to "much improved" at two weeks and increased to "very much improved" at eight weeks. There was an average 24.93-percent improvement in texture and an average 10.30-percent improvement in skin tone (color) evenness. AK lesion clearance ranged from 70 to 100 percent, with the mean at 89.2±14.9 percent. Three subjects achieved 100-percent clearance. The mean pain score during red-light illumination was 3.2±1.6. All subjects completed the study.ResultsInvestigator- and subject-graded GAIS scores showed a sharp increase to "much improved" at two weeks and increased to "very much improved" at eight weeks. There was an average 24.93-percent improvement in texture and an average 10.30-percent improvement in skin tone (color) evenness. AK lesion clearance ranged from 70 to 100 percent, with the mean at 89.2±14.9 percent. Three subjects achieved 100-percent clearance. The mean pain score during red-light illumination was 3.2±1.6. All subjects completed the study.The study included a small number of subjects (N=5).LimitationsThe study included a small number of subjects (N=5).Our results indicate that red light PDT using microneedling-assisted delivery of 10% ALA gel and a short 30-minute incubation is a safe and tolerable procedure producing good cosmetic outcomes in several skin quality parameters, such as texture and skin tone evenness, as well as an AK lesion clearance rate of 89.2 percent at Week 8, relatively low pain scores, and a reduced PDT treatment time.ConclusionOur results indicate that red light PDT using microneedling-assisted delivery of 10% ALA gel and a short 30-minute incubation is a safe and tolerable procedure producing good cosmetic outcomes in several skin quality parameters, such as texture and skin tone evenness, as well as an AK lesion clearance rate of 89.2 percent at Week 8, relatively low pain scores, and a reduced PDT treatment time. We evaluated the cosmetic outcome and clearance of actinic keratoses (AKs) using photodynamic therapy (PDT) with microneedling-assisted delivery of 10% aminolevulinic acid (ALA) gel (Ameluz®, Biofrontera, Woburn, MA) with 30-minute incubation followed by 10-minute illumination with a red light (BF-RhodoLED®, 635nm, 37 J/cm ). Five subjects were treated with red light PDT using microneedling-assisted delivery of 10% ALA gel. ALA gel was applied on the face and incubated for 30 minutes without occlusion, followed by illumination with a red light for 10 minutes (635nm, 37 J/cm ). Follow-up (FU) visits were made at Weeks 1, 2, 4, and 8. The primary endpoints were changes in subject- and investigator-graded Global Aesthetic Improvement Scale (GAIS) scores and assessment of quality in wrinkle, color evenness, texture, spot, and pore analyses with Canfield Visia-CR imaging system. Secondary endpoints were: 1) AK clearance as quantified by the count of AKs at eight-week FU versus baseline and 2) safety as measured by subject-reported pain (10-point VAS scale) during red-light illumination and adverse events. Investigator- and subject-graded GAIS scores showed a sharp increase to "much improved" at two weeks and increased to "very much improved" at eight weeks. There was an average 24.93-percent improvement in texture and an average 10.30-percent improvement in skin tone (color) evenness. AK lesion clearance ranged from 70 to 100 percent, with the mean at 89.2±14.9 percent. Three subjects achieved 100-percent clearance. The mean pain score during red-light illumination was 3.2±1.6. All subjects completed the study. The study included a small number of subjects (N=5). Our results indicate that red light PDT using microneedling-assisted delivery of 10% ALA gel and a short 30-minute incubation is a safe and tolerable procedure producing good cosmetic outcomes in several skin quality parameters, such as texture and skin tone evenness, as well as an AK lesion clearance rate of 89.2 percent at Week 8, relatively low pain scores, and a reduced PDT treatment time. |
Author | Yousefian, Faraz Schwartz, Ziv Goldenberg, Gary |
AuthorAffiliation | 2 Dr. Schwartz is with Sidney Kimmel Medical College at Thomas Jefferson University, Department of Dermatology and Cutaneous Biology in Philadelphia, Pennsylvania 3 Dr. Yousefian is with the Philadelphia College of Osteopathic Medicine, Department of Dermatology and Mohs Surgery in Roswell, Georgia 1 Dr. Goldenberg is with the Icahn School of Medicine at Mount Sinai Hospital, Department of Dermatology in New York, New York |
AuthorAffiliation_xml | – name: 1 Dr. Goldenberg is with the Icahn School of Medicine at Mount Sinai Hospital, Department of Dermatology in New York, New York – name: 3 Dr. Yousefian is with the Philadelphia College of Osteopathic Medicine, Department of Dermatology and Mohs Surgery in Roswell, Georgia – name: 2 Dr. Schwartz is with Sidney Kimmel Medical College at Thomas Jefferson University, Department of Dermatology and Cutaneous Biology in Philadelphia, Pennsylvania |
Author_xml | – sequence: 1 givenname: Gary surname: Goldenberg fullname: Goldenberg, Gary organization: Dr. Goldenberg is with the Icahn School of Medicine at Mount Sinai Hospital, Department of Dermatology in New York, New York – sequence: 2 givenname: Ziv surname: Schwartz fullname: Schwartz, Ziv organization: Dr. Schwartz is with Sidney Kimmel Medical College at Thomas Jefferson University, Department of Dermatology and Cutaneous Biology in Philadelphia, Pennsylvania – sequence: 3 givenname: Faraz surname: Yousefian fullname: Yousefian, Faraz organization: Dr. Yousefian is with the Philadelphia College of Osteopathic Medicine, Department of Dermatology and Mohs Surgery in Roswell, Georgia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40256344$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkdtu1DAQhiPUim5LXwH5BqlcRPIhjmNuULTqQsWiVmi5jhx7sjFy7CV2Wu0L8ZyYUlA7N6M5_d8vzXlx4oOHV8WK1o0sJRH8pFgRWZGSikaeFZcx_sA5WCO5qF4XZxWmvGZVtSp-fQNTbu1-TOhuDCmYo1eT1Wg3wqwOR_Rg04gIfofayfrg4H5x1ud5q61BV-22fY82wbnwYP0efbV6zkbAuD-V9SiNgHYzqDSBTygMaKO0VS5fp0eVLxmSQrTxA1qHOEHKPeUNWj9C8uLtknSYIL4pTgflIlw-5Yvi--Z6t_5cbm8_3azbbXkghOJSDUC4HIzmogchesMHyijuMVMS9GAEpZXhhBhVQd0L3siBaMmwkURC0w_sovj4V_ew9BMYnW3PynWH2U5qPnZB2e7lxNux24f7LtOxqGucFa6eFObwc4GYuslGDc4pD2GJHSOSMl5XuM6rb5_D_lP-fYf9Bt__kfk |
ContentType | Journal Article |
Copyright | Copyright © 2025. Matrix Medical Communications. All rights reserved. Copyright © 2025. Matrix Medical Communications. All rights reserved. 2025 |
Copyright_xml | – notice: Copyright © 2025. Matrix Medical Communications. All rights reserved. – notice: Copyright © 2025. Matrix Medical Communications. All rights reserved. 2025 |
DBID | NPM 7X8 5PM |
DatabaseName | PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2689-9175 |
EndPage | 56 |
ExternalDocumentID | PMC12007660 40256344 |
Genre | Journal Article |
GroupedDBID | --- 53G AAKDD AAWTL ABDBF ACUHS ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL DIK E3Z EBD EBS EJD ESX F5P HYE NPM OK1 RPM TUS 7X8 5PM |
ID | FETCH-LOGICAL-p1120-afe159fdc57be77bd5f2320b03a9ecfd7224d511da4e6b7589f1c930d919e8bf3 |
ISSN | 1941-2789 |
IngestDate | Thu Aug 21 18:27:45 EDT 2025 Mon Apr 21 19:00:50 EDT 2025 Wed Apr 23 01:40:02 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Red-light photodynamic therapy safety tolerability aminolevulinic acid cosmetic actinic keratosis |
Language | English |
License | Copyright © 2025. Matrix Medical Communications. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p1120-afe159fdc57be77bd5f2320b03a9ecfd7224d511da4e6b7589f1c930d919e8bf3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 FUNDING: Funding was provided by Biofrontera Inc. DISCLOSURES: The authors declare no conflicts of interest relevant to the content of this article. |
PMID | 40256344 |
PQID | 3192356406 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_12007660 proquest_miscellaneous_3192356406 pubmed_primary_40256344 |
PublicationCentury | 2000 |
PublicationDate | 2025-Apr 20250401 |
PublicationDateYYYYMMDD | 2025-04-01 |
PublicationDate_xml | – month: 04 year: 2025 text: 2025-Apr |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of clinical and aesthetic dermatology |
PublicationTitleAlternate | J Clin Aesthet Dermatol |
PublicationYear | 2025 |
Publisher | Matrix Medical Communications |
Publisher_xml | – name: Matrix Medical Communications |
SSID | ssj0000389574 |
Score | 2.3382082 |
Snippet | We evaluated the cosmetic outcome and clearance of actinic keratoses (AKs) using photodynamic therapy (PDT) with microneedling-assisted delivery of 10%... |
SourceID | pubmedcentral proquest pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 51 |
SubjectTerms | Original Research |
Title | Red-Light Photodynamic Therapy with 10% Aminolevulinic Acid (ALA) Following Microneedling in the Treatment of Facial Actinic Keratosis: Cosmetic and Clinical Outcomes |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40256344 https://www.proquest.com/docview/3192356406 https://pubmed.ncbi.nlm.nih.gov/PMC12007660 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1da9swFBVrH8Zexr7XfaHCBhvBw45kO96bCU3LlrRjSyDsxciWRDxSuzROC_1B-527V_4ueej2YoKTyInuQffo-NxrQt4rTEvS5ZY3GimL68CzBHMSiw19F7LXELIeViPPTr2TBf-6dJetmGOqS4r4c3Kzs67kf6IK5yCuWCX7D5FtBoUT8BriC0eIMBzvFOMfSlpT3F0Pvq_yIpfl0-XRRYGdAkqN1bE_DN1BeJ5m-VpdbU0h5CBMUiMehNMQZYEJgCG_RtFghv68DDLauqp1QV46b8zowCwnwojsIayTONI3bMqcb1LjrBvnm3NVd4Ad1zWXZ9sC_nzlVfzdorPDhZv6TNM6FhLVygwjMW0UPeH_OF_L1pR2LFoX889kdQ1zZATxX-lVZznbKJ2WOu9EXIqbrtAxdDv-mHJtDrhjYeHu7sW7VSbMSly1se012D49iyaL6TSaHy3ne2SPObwj75jUDfTN9UsnQnWxXTuP2wbaDiOZPyIPq-mjYYmLx-Seyp6Q-7PKLPGU_GngQbvwoBU8KMKDAjxoHxwUwUE_AjQ-0QYYtAcMmmYUQkQbYNBc0xIYtAIGbYDxhdawoBBdWsOC1rB4RhaTo_n4xKoey2FdADm3LaEVcGAtE9ePle_H0tVAy-3YZiJQiZY-sEIJPF4KrrwY9qOBdpKA2TJwAjWKNXtO9jP4xS8JVTHjsfCAQmIySeRIMMYTn2tHKx-I4wE5rCc_gmUP72WJTAFuIoY7E9cDOnpAXpTBiC7K_iwRRx7POHx71AtT8wFsqd5_J0tXprW6g9K959mv7nDh1-RBC9M3ZL-43Kq3wFCL-J1B1V9rL55B |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Red-Light+Photodynamic+Therapy+with+10%25+Aminolevulinic+Acid+%28ALA%29+Following+Microneedling+in+the+Treatment+of+Facial+Actinic+Keratosis%3A+Cosmetic+and+Clinical+Outcomes&rft.jtitle=The+Journal+of+clinical+and+aesthetic+dermatology&rft.au=Goldenberg%2C+Gary&rft.au=Schwartz%2C+Ziv&rft.au=Yousefian%2C+Faraz&rft.date=2025-04-01&rft.issn=1941-2789&rft.volume=18&rft.issue=4&rft.spage=51&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1941-2789&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1941-2789&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1941-2789&client=summon |